In humans IGF-II was suggested to play a role in development of CRC, as substantiated by findings showing that IGF-II is overexpressed in about 44% of all colorectal tumors due to a loss of imprinting (LOI) in the IGF2 gene [13]. Here, IGF2 is linked to colorectal neoplasm.